Therapeutic potential for novel drugs targeting the type 1 cholecystokinin receptor
about
Analgesic effect of Coptis chinensis rhizomes (Coptidis Rhizoma) extract on rat model of irritable bowel syndromeThe Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptorsThe gastrin and cholecystokinin receptors mediated signaling network: a scaffold for data analysis and new hypotheses on regulatory mechanismsUp-regulation of cholesterol absorption is a mechanism for cholecystokinin-induced hypercholesterolemiaFluorescence polarization screening for allosteric small molecule ligands of the cholecystokinin receptor.Differential expression of cholecystokinin A receptor in gallbladder cancer in the young and elderly suggests two subsets of the same disease?Comparative pharmacology of cholecystokinin induced activation of cultured vagal afferent neurons from rats and miceMolecular basis for binding and subtype selectivity of 1,4-benzodiazepine antagonist ligands of the cholecystokinin receptor.Photodynamic Physiology-Photonanomanipulations in Cellular Physiology with Protein Photosensitizers.Regulation of acinar cell function in the pancreas.The cholecystokinin CCK2 receptor antagonist, JNJ-26070109, inhibits gastric acid secretion and prevents omeprazole-induced acid rebound in the rat.Molecular pharmacology of G protein-coupled receptors. Editorial.Species- and dose-specific pancreatic responses and progression in single- and repeat-dose studies with GI181771X: a novel cholecystokinin 1 receptor agonist in mice, rats, and monkeys.
P2860
Q24631963-32C7DDE4-9623-44C0-B88B-83BF896FBA49Q30486707-C017BD98-D246-4827-A972-D5815C1F3980Q30982358-F5C7F722-7686-4273-ACFD-AB86A30BA24DQ33676535-FE51F7D9-F22E-48FF-B861-7B8FC677AE76Q33843640-1E9D3B3F-7CC9-4F4B-9043-0477E9289D68Q33849781-68005C7E-90FF-4C18-95E3-69C6E7BB2D48Q34238683-1BB3DC12-220B-4789-8A05-822E242F720FQ36002904-40D25EB8-9C1E-4B9D-9731-DF2405CAEBC0Q37736131-C8520EE5-5EAA-4ABD-8B1E-EE0000EBE88AQ37772044-988BA7BF-A6EE-45A9-9862-A02D410E27FCQ42123431-9C9ADE6E-4CF0-485E-9249-18426802C3C4Q42870689-6E23B7AB-D79F-42A2-94C5-6DBB6ABAE59BQ46976579-435DEDF2-4347-4AE1-85F3-1AAB935097E7
P2860
Therapeutic potential for novel drugs targeting the type 1 cholecystokinin receptor
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Therapeutic potential for novel drugs targeting the type 1 cholecystokinin receptor
@ast
Therapeutic potential for novel drugs targeting the type 1 cholecystokinin receptor
@en
Therapeutic potential for novel drugs targeting the type 1 cholecystokinin receptor
@nl
type
label
Therapeutic potential for novel drugs targeting the type 1 cholecystokinin receptor
@ast
Therapeutic potential for novel drugs targeting the type 1 cholecystokinin receptor
@en
Therapeutic potential for novel drugs targeting the type 1 cholecystokinin receptor
@nl
prefLabel
Therapeutic potential for novel drugs targeting the type 1 cholecystokinin receptor
@ast
Therapeutic potential for novel drugs targeting the type 1 cholecystokinin receptor
@en
Therapeutic potential for novel drugs targeting the type 1 cholecystokinin receptor
@nl
P2860
P1476
Therapeutic potential for novel drugs targeting the type 1 cholecystokinin receptor
@en
P2093
Erin E Cawston
Laurence J Miller
P2860
P304
P356
10.1111/J.1476-5381.2009.00489.X
P407
P577
2010-03-01T00:00:00Z